Heart Failure with Preserved Ejection Fraction

Adam Meyer; Martin Kerrigan

doi:10.1016/j.ehmc.2015.03.009

Heart Failure with Preserved Ejection Fraction

Adam Meyer, Martin Kerrigan

Division of Hospital Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Heart failure with preserved ejection fraction (HFpEF) affects approximately half of all patients with heart failure and is a common reason for admission to the hospital. The most common factors associated with developing HFpEF include age, female sex, uncontrolled hypertension, and obesity. Management of HFpEF consists of symptomatic control with diuretics and controlling comorbidities such as hypertension and atrial arrhythmias. Choice of antihypertensive is guided by underlying comorbidities; studies have shown no mortality benefit with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). However, ACE inhibitors and ARBs showed some reduction in hospital readmissions for patients with HFpEF.

Original language	English
Pages (from-to)	283-296
Number of pages	14
Journal	Hospital Medicine Clinics
Volume	4
Issue number	3
DOIs	https://doi.org/10.1016/j.ehmc.2015.03.009
State	Published - Jul 1 2015

Keywords

Diastolic
HFpEF
Heart failure
Preserved ejection fraction

Access to Document

10.1016/j.ehmc.2015.03.009

Cite this

@article{c966db557ce34682a74db524a7852348,

title = "Heart Failure with Preserved Ejection Fraction",

abstract = "Heart failure with preserved ejection fraction (HFpEF) affects approximately half of all patients with heart failure and is a common reason for admission to the hospital. The most common factors associated with developing HFpEF include age, female sex, uncontrolled hypertension, and obesity. Management of HFpEF consists of symptomatic control with diuretics and controlling comorbidities such as hypertension and atrial arrhythmias. Choice of antihypertensive is guided by underlying comorbidities; studies have shown no mortality benefit with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). However, ACE inhibitors and ARBs showed some reduction in hospital readmissions for patients with HFpEF.",

keywords = "Diastolic, HFpEF, Heart failure, Preserved ejection fraction",

author = "Adam Meyer and Martin Kerrigan",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = jul,

day = "1",

doi = "10.1016/j.ehmc.2015.03.009",

language = "English",

volume = "4",

pages = "283--296",

journal = "Hospital Medicine Clinics",

issn = "2211-5943",

number = "3",

}

TY - JOUR

T1 - Heart Failure with Preserved Ejection Fraction

AU - Meyer, Adam

AU - Kerrigan, Martin

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Heart failure with preserved ejection fraction (HFpEF) affects approximately half of all patients with heart failure and is a common reason for admission to the hospital. The most common factors associated with developing HFpEF include age, female sex, uncontrolled hypertension, and obesity. Management of HFpEF consists of symptomatic control with diuretics and controlling comorbidities such as hypertension and atrial arrhythmias. Choice of antihypertensive is guided by underlying comorbidities; studies have shown no mortality benefit with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). However, ACE inhibitors and ARBs showed some reduction in hospital readmissions for patients with HFpEF.

AB - Heart failure with preserved ejection fraction (HFpEF) affects approximately half of all patients with heart failure and is a common reason for admission to the hospital. The most common factors associated with developing HFpEF include age, female sex, uncontrolled hypertension, and obesity. Management of HFpEF consists of symptomatic control with diuretics and controlling comorbidities such as hypertension and atrial arrhythmias. Choice of antihypertensive is guided by underlying comorbidities; studies have shown no mortality benefit with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). However, ACE inhibitors and ARBs showed some reduction in hospital readmissions for patients with HFpEF.

KW - Diastolic

KW - HFpEF

KW - Heart failure

KW - Preserved ejection fraction

UR - http://www.scopus.com/inward/record.url?scp=84931336385&partnerID=8YFLogxK

U2 - 10.1016/j.ehmc.2015.03.009

DO - 10.1016/j.ehmc.2015.03.009

M3 - Review article

AN - SCOPUS:84931336385

SN - 2211-5943

VL - 4

SP - 283

EP - 296

JO - Hospital Medicine Clinics

JF - Hospital Medicine Clinics

IS - 3

ER -

Heart Failure with Preserved Ejection Fraction

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this